tailieunhanh - The ABNL-MARRO 001 study: A phase 1–2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes

Myelodysplastic/myeloproliferative neoplasms (MDS/MPN) comprise several rare hematologic malignancies with shared concomitant dysplastic and proliferative clinicopathologic features of bone marrow failure and propensity of acute leukemic transformation, and have significant impact on patient quality of life. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN